Jeil Pharmaceutical Co.,Ltd (KRX:271980)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,300
+80 (0.71%)
Feb 21, 2025, 9:00 AM KST

KRX:271980 Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Feb '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Market Capitalization
164,658249,173306,279494,529--
Market Cap Growth
-9.14%-18.65%-38.07%---
Enterprise Value
218,473307,855346,439503,520--
Last Close Price
11300.0017027.1720848.4433522.7261880.4435742.22
PE Ratio
-49.79----
PS Ratio
0.240.340.420.71--
PB Ratio
0.981.461.872.96--
P/TBV Ratio
1.331.621.993.01--
P/FCF Ratio
14.29--35.95--
P/OCF Ratio
13.47--25.89--
EV/Sales Ratio
0.310.420.480.72--
EV/EBITDA Ratio
-16.50----
EV/EBIT Ratio
-34.64----
EV/FCF Ratio
18.96--36.60--
Debt / Equity Ratio
0.420.420.330.290.290.19
Debt / EBITDA Ratio
-3.82--2.304.50
Debt / FCF Ratio
6.62--3.47-1.16
Asset Turnover
1.401.541.641.681.71-
Inventory Turnover
4.395.195.615.155.53-
Quick Ratio
0.690.660.710.780.750.84
Current Ratio
1.091.041.121.281.271.27
Return on Equity (ROE)
-21.80%3.11%-9.06%-8.82%4.08%-
Return on Assets (ROA)
-2.83%1.18%-1.89%-1.55%1.92%-
Return on Capital (ROIC)
-5.43%2.41%-3.85%-2.97%3.67%-
Return on Capital Employed (ROCE)
-4.86%--6.49%-
Earnings Yield
-21.76%2.01%-4.27%-2.52%--
FCF Yield
7.00%-4.45%-8.56%2.78%--
Dividend Yield
0.44%0.29%0.24%---
Payout Ratio
0.00%14.55%--14.79%-
Buyback Yield / Dilution
-0.00%0.02%0.23%0.04%0.41%-
Total Shareholder Return
0.44%0.32%0.47%0.04%0.41%-
Source: S&P Capital IQ. Standard template. Financial Sources.